This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Wisniak J, Thomas Graham. I. Contribution to thermodynamics, chemistry, and the occlusion of gases, Education Quimica, 2013; 24(3):316-325WisniakJThomasGraham.IContribution to thermodynamics, chemistry, and the occlusion of gases, Education Quimica201324331632510.1016/S0187-893X(13)72481-9Search in Google Scholar
Henderson LW, A Tribute to Willem Johan Kolff, M.D., 1912–2009, JASN, 2009; 20(5): 923-924HendersonLWA Tribute to Willem Johan Kolff, M.D1912–2009, JASN200920592392410.1681/ASN.2009030236Search in Google Scholar
Gyavali B, Ramakrishna K, Dhamon AS, Sepsis: The evolution in definition, pathophysiology, and management, SAGE Open Medicine, 2019, 7:1-13GyavaliBRamakrishnaKDhamonASSepsis: The evolution in definition, pathophysiology, and managementSAGE Open Medicine2019711310.1177/2050312119835043642964230915218Search in Google Scholar
Al-Fares A, Pettenuzzo T, Del Sorbo L, Extracorporeal life support and systemic inflammation, Intensive Care Medicine Experimental 2019, 7(Suppl 1):46, doi: 10.1186/s40635-019-0249-yAl-FaresAPettenuzzoTDelSorbo LExtracorporeal life support and systemic inflammationIntensive Care Medicine Experimental20197Suppl 14610.1186/s40635-019-0249-y665864131346840Open DOISearch in Google Scholar
Cruz DN, Antonelli M, Fumagalli R et al, Early use of Polymyxin-B hemoperfusion in abdominal septic shock. The EUPHAS randomized controlled trial, JAMA, 2009; 301(23):2445-2452CruzDNAntonelliMFumagalliRet alEarly use of Polymyxin-B hemoperfusion in abdominal septic shockThe EUPHAS randomized controlled trial, JAMA2009301232445245210.1001/jama.2009.85619531784Search in Google Scholar
Cutuli SL, Artigas A, Fumagalli R et al, Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry, Annals of Intensive Care, 2016, 6(77) doi.org/10.1186/s13613-016-0178-9CutuliSLArtigasAFumagalliRPolymyxin-B hemoperfusion in septic patients: analysis of a multicenter registryAnnals of Intensive Care2016677doi.org/10.1186/s13613-016-0178-910.1186/s13613-016-0178-9497723227502196Search in Google Scholar
Payen DM, Guilhot J, Launey Y et al, Early use of a polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized trial, Intensive Care Medicine, 2015, 41(6):975-984PayenDMGuilhotJLauneyYEarly use of a polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized trialIntensive Care Medicine201541697598410.1007/s00134-015-3751-z447772525862039Search in Google Scholar
Bonavia A, Groff A, Karamchandani K, Singbartl K, Clinical utility of extracorporeal cytokine hemoadsorbtion therapy: a literature review, Blood Purif, 2018, 46:337-349BonaviaAGroffAKaramchandaniKSingbartlKClinical utility of extracorporeal cytokine hemoadsorbtion therapy: a literature reviewBlood Purif20184633734910.1159/00049237930176653Search in Google Scholar
Napp Cl, Ziegeler S, Kindgen-milles D, Rationale of hemoadsorbtion during extracorporeal membrane oxygenation support, Blood Purif, 2019, 48:203-214NappClZiegelerSKindgen-millesDRationale of hemoadsorbtion during extracorporeal membrane oxygenation supportBlood Purif20194820321410.1159/000500015687872831096211Search in Google Scholar
Mehta Y, Mehta C, Kumar A et al, Experience with hemoadsorbtion (CytoSorb) in the management of septic shock patients, World J Crit Care Med, 2020, 9(1):1-12MehtaYMehtaCKumarAExperience with hemoadsorbtion (CytoSorb) in the management of septic shock patientsWorld J Crit Care Med20209111210.5492/wjccm.v9.i1.1703162332104647Search in Google Scholar
Schadler D, Pausch C, Heise D et al, The effect of a novel extracorporeal cytokine hemoadsorbtion device on IL-6 elimination in septic patients: A randomized controlled trial, Plos One, 2017, 12(10):e0187015SchadlerDPauschCHeiseDThe effect of a novel extracorporeal cytokine hemoadsorbtion device on IL-6 elimination in septic patients: A randomized controlled trialPlos One20171210e018701510.1371/journal.pone.0187015566222029084247Search in Google Scholar
Honore PM, De Bels D, Gutierrez LB, Spapen HD, Hemoadsorbtion therapy in the critically ill: solid base but clinical haze, Ann. Intensive Care, 2019, 9:22, doi.org/10.1186/s13613-019-0491-1HonorePMDeBels DGutierrezLBSpapenHDHemoadsorbtion therapy in the critically ill: solid base but clinical haze, AnnIntensive Care2019922doi.org/10.1186/s13613-019-0491-110.1186/s13613-019-0491-1635588830706173Search in Google Scholar
Lumlertgul N, Srisawat N, The haemodynamic effect of oxiris haemofilter in septic shock patients requiring renal support: a single center experience, The International Journal of Artificial Organs, 2020, doi: 10.1177/0391398820917150LumlertgulNSrisawatNThe haemodynamic effect of oxiris haemofilter in septic shock patients requiring renal support: a single center experienceThe International Journal of Artificial Organs202010.1177/039139882091715032393096Open DOISearch in Google Scholar
Broman ME, Hansson F, Vincent JL, Bodelsson M, Endotoxin and cytokine reducing properties of the Oxiris membrane in patients with septic shock: a randomized crossover double-blind study, PLoS One, 2019, 14(8):e0220444, doi: 10.1371/journal.pone.0220444BromanMEHanssonFVincentJLBodelssonMEndotoxin and cytokine reducing properties of the Oxiris membrane in patients with septic shock: a randomized crossover double-blind studyPLoS One2019148e022044410.1371/journal.pone.0220444667509731369593Open DOISearch in Google Scholar
Schwindenhammer V, Girardot T, Chaulier K et al, Oxiris use in septic shock: Experience of Two French Centres, Blood Purif. 2019;47 Suppl 3:1-7. doi: 10.1159/000499510.SchwindenhammerVGirardotTChaulierKOxiris use in septic shock: Experience of Two French CentresBlood Purif201947 Suppl31710.1159/00049951030982028Open DOISearch in Google Scholar
Malard B, Lambert C, Kellum JA, In vitro comparison of the adsorbtion of inflammatory mediators by blood purification devices, Intensive Care Medicine Experimental, 2018, 6:12, https://doi.org/10.1186/s40635-018-0177-2MalardBLambertCKellumJAIn vitro comparison of the adsorbtion of inflammatory mediators by blood purification devicesIntensive Care Medicine Experimental2018612https://doi.org/10.1186/s40635-018-0177-210.1186/s40635-018-0177-2593560129728790Search in Google Scholar
Ankawi G, Neri M, Zhang J et al, Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls, Critical Care, 2018, 22:262AnkawiGNeriMZhangJExtracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfallsCritical Care20182226210.1186/s13054-018-2181-z620285530360755Search in Google Scholar
